Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Experimental and Translational Medicine

Home
Menu

Day Laboratory

Day Lab research programme has led to significant research outputs of sustained quality, including Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø's first biomaterial for tissue regeneration granted approval for clinical use by the Medicines and Healthcare Products Regulatory Agency and associated first-in-human phase I/II clinical trial. The technology is backed by a portfolio of patent families, industry collaborations and licencing agreements.

  • The core areas of research are:
  • Bowel & Bladder Health
  • Cardiovascular Disease
  • Cell Delivery
  • Characterizing the Immune Response
  • Combating Antimicrobial Resistance
  • Drug Delivery
  • Immunotherapy
  • Magnetic Actuation
  • TIPS Microspheres